Why the Market Is Moving Toward PDRN

The global salmon PDRN market is transitioning from a niche pharmaceutical ingredient into a mainstream bio-stimulator: valued at roughly USD 53 million in 2025 and projected to reach USD 76 million in 2026, with the wider PDRN injectable market forecast to grow at a 16.2% CAGR through 2033. Salmon DNA still holds an 88% share of the DNA-derived materials segment — for now. Demand splits across two channels: medical aesthetics, where PDRN accelerates wound healing and collagen synthesis after microneedling or laser treatment, and consumer skincare, where it appears in “skin booster” serums targeting acne scarring, under-eye repair and barrier restoration.

Outperforming the Animal-Derived Benchmark

Common plant-based alternatives — Rose and Centella extracts among them — have historically tested as biologically inactive or even inhibitory in PDRN bioassays. Microalgae CV-66 PDRN is the exception: the only plant-based derivative shown to outperform salmon PDRN rather than merely approximate it.

•Higher whitening potency — CV-66 reaches an EC50 of 13 µg/mL, meaning it achieves the same skin-whitening effect as salmon PDRN using only about a third of the active concentration — more efficacy per gram, and room for leaner formulations.

•Faster wound healing — in wound-healing bioassays, CV-66 delivered a 178.8% healing rate, the strongest result across all sources tested.

The Data: Cell Migration & Scratch Assays

Both studies simulate real tissue injury and measure how quickly and completely cells close the gap over a fixed window.

72-Hour Migration Assay

A microscopic gap is created and tracked for 72 hours to see how far cells travel across it — faster, further migration signals a more energizing ingredient. The untreated control closed 1.65 cm; salmon PDRN improved that to 2.15 cm; Microalgae CV-66 PDRN reached 2.95 cm — over 37% further than the leading animal-derived alternative.

Here, cells must both migrate into the gap and multiply to rebuild tissue. At the 24-hour mark, CV-66-treated cultures were already flooding the wound area; by 72 hours the gap had reached near-complete closure. The control showed little progress even at 72 hours, and salmon PDRN left a visible, unclosed path.

Care Benefits

•Post-procedure recovery — supports faster, more complete skin repair after microneedling, laser resurfacing or other in-clinic procedures.

•Brightening & tone correction — high whitening potency at low use levels suits brightening serums and pigmentation-focused formulas.

•Ethical, high-performance positioning — delivers benchmark-beating performance while remaining 100% vegan — a genuine upgrade path for brands moving away from marine-derived actives.